Vascular Perfusion Solutions and Unravel Biosciences announce partnership to modulate endothelial activation during heart preservation to improve heart transplant outcomes
November 27, 2023 08:47 ET
|
Vascular Perfusion Solutions
BOSTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Vascular Perfusion Solutions (VPS) and Unravel Biosciences, Inc. (“Unravel”) are partnering to develop a proprietary perfusion solution that will...